MELISSA HALVERSON: Open Payments
NPI 1558887174 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 49 payments from 14 companies in 2025. Trend: 2023 $965 · 2024 $903 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $147 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| Lilly USA, LLC | 4 | $73 |
| Gilead Sciences, Inc. | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 1 | $31 |
| GENZYME CORPORATION | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: VOQUEZNA, DUPIXENT, ENTYVIO, Wegovy, RINVOQ, LINZESS, CREON, EOHILIA.
Industry payments across IL — which companies pay providers there.
